US 12,486,507 B2
Composition for regulating production of interfering ribonucleic acid
Bradley G. Thompson, Calgary (CA)
Assigned to Wyvern Pharmaceuticals Inc., Calgary (CA)
Filed by Wyvern Pharmaceuticals Inc., Calgary (CA)
Filed on Oct. 30, 2024, as Appl. No. 18/932,265.
Application 18/932,265 is a division of application No. 18/518,069, filed on Nov. 22, 2023.
Prior Publication US 2025/0163427 A1, May 22, 2025
Int. Cl. C12N 15/113 (2010.01); C12N 15/86 (2006.01)
CPC C12N 15/1137 (2013.01) [C12N 15/86 (2013.01); C12N 2310/141 (2013.01); C12N 2750/14143 (2013.01); C12Y 207/01 (2013.01)] 2 Claims
 
1. A composition that comprises a recombinant plasmid (RP) comprising a sequence of nucleotides that is SEQ ID NO: 7.